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Available online 19 December 2006Edited by Hans EklundAbstract The GcpE enzyme converts 2-C-methyl-D-erythritol-
2,4-cyclodiphosphate (MEcPP) into (E)-4-hydroxy-3-methyl-
but-2-enyl diphosphate (HMBPP) in the penultimate step of
the DOXP pathway for isoprene biosynthesis. Puriﬁcation of
the enzyme under exclusion of air leads to a preparation that
contains solely [4Fe–4S] clusters. Kinetic studies showed that
in the presence of the artiﬁcial reductant dithionite and MEcPP
a new transient iron–sulfur-based signal is detected in electron
paramagnetic resonance (EPR) spectroscopy. Similarity of this
EPR signal to that detected in ferredoxin:thioredoxin reductase
indicates that during the reaction an intermediate is directly
bound to the active-site cluster.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The discovery of the 1-deoxy-D-xylulose 5-phosphate
(DOXP) pathway for isoprene synthesis [1,2] (Fig. 1) opened
up the way for the development of novel anti-infective drugs
that can cure a host of diseases including tuberculosis, malaria,
cholera, anthrax and pseudomonas infections [3]. The poten-
tial broad application of these drugs comes from the fact that
these organisms use the DOXP pathway as the sole pathway
for the synthesis of isoprene units, while animals use the mev-
alonate pathway for the synthesis of these essential biological
molecules. Fosmidomycin and derivatives of this compound
are the only known compounds that target an enzyme, DOXP
reductoisomerase, in the DOXP pathway [4,5] (Fig. 1).
Patients suﬀering from acute uncomplicated Plasmodium falci-
parum infections could be successfully treated with fosmido-
mycin, but in some patients the parasite reappeared after
termination of the treatment [6]. An overall cure rate of
95%, however, was achieved when fosmidomycin was tested
in combination with clindamycin [7], an inhibitor of the pro-*Corresponding author. Fax: +1 334 844 6959.
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doi:10.1016/j.febslet.2006.12.026karyote-type translation machinery of the plastid-like orga-
nelle (the so-called apicoplast) present in malaria parasites.
Based on the proven clinical eﬃcacy of fosmidomycin it is
highly desirable to characterize the enzymes that constitute
the DOXP pathway, both structurally and mechanistically.
This knowledge can be used to design new anti-infective drugs,
which when used in combination with fosmidomycin are ex-
pected to show a pronounced synergistic increase in eﬃcacy.
This research is timely since for the above mentioned diseases
no working drugs or vaccines are available or existing drugs
are quickly becoming useless due to the rise of multi-drug-
resistant strains.
In this paper, we present our data on the (E)-4-hydroxy-3-
methylbut-2-enyl diphosphate synthase (also called GcpE or
IspG) (Fig. 1). Previously, it was shown that DgcpE deletion
mutants accumulate 2-C-methyl-D-erythritol-2,4-cyclodiphos-
phate (MEcPP) [8,9] and that the recombinant GcpE protein
from Thermus thermophilus enzymatically converts MEcPP
into (E)-4-hydroxy-3-methylbut-2-enyl diphosphate in the
presence of dithionite as reductant [10]. For a full conversion
two reducing equivalents are needed. GcpE is an iron–sulfur-
cluster containing protein. Puriﬁcation of GcpE under air
resulted in an almost colorless enzyme with very low cluster
content [11,12]. One way to obtain active protein is by insert-
ing a new cluster into the apoenzyme through a reconstitution
procedure. This procedure, however, can result in the presence
of a mix of clusters types. Sequence alignments of the available
GcpE sequences [13–17] show that there are only three highly
conserved cysteine residues that in principle can coordinate a
[4Fe–4S] cluster that contains a unique Fe atom or a [3Fe–4S]
cluster. In the case of enzyme from Thermosynechococcus
elongatus the reconstitution procedure resulted in an enzyme
preparation that showed an absorption spectrum with bands
at 305, 395 and 585 nm, which was interpreted as being due
to a [4Fe–4S]+ cluster [12]. No additional methods were used
to conﬁrm this. The 585 nm band, however, is typically only
seen in proteins that contain [2Fe–2S]+ clusters [18,19]. Mo¨ss-
bauer experiments on reconstituted enzyme from Escherichia
coli and Arabidopsis thaliana showed that the protein samples
contained mainly [4Fe–4S] clusters but also a small amount of
diﬀerent iron species that could be due to either the presence of
small super-paramagnetic ferric iron clusters or to [3Fe–4S]0
clusters [20]. Since the reported speciﬁc activity for GcpE is rel-
atively low it is important to establish if the activity is due toblished by Elsevier B.V. All rights reserved.
Fig. 1. The DOXP pathway for isoprene synthesis. The insert shows the structure of fosmidomycin and its derivative FR900098.
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cluster types that are present. For example, genetic studies
aimed at the conversion of cluster types in enzymes showed
that the replacement of a [3Fe–4S] cluster with a [4Fe–4S] clus-
ter in fumarate reductase from E. coli resulted in a 50% de-
crease in activity [21]. The opposite, however, was detected
for a hydrogenase where the replacement of a [4Fe–4S] cluster
with a [3Fe–4S] cluster resulted in lower activity [22]. Here, we
show that puriﬁcation under exclusion of oxygen resulted in an
enzyme preparation that solely contains 4Fe clusters and that
the cluster is probably directly involved in binding of a reac-
tion intermediate.Fig. 2. Absorption spectra of GcpE. The as-isolated enzyme
(0.040 mM) incubated for a total time of 60 min in the presence of
0.28 mM dithionite and subsequently for a total time of 60 min in the
presence of 1.66 mM dithionite. Spectra were taken after 1, 2, 5, 10, 15,
30, 45, and 60 min. The band at 330 nm is due to dithionite.2. Materials and methods
The gcpE gene of T. thermophilus was overexpressed in an E. coli
host and the gcpE product was puriﬁed as described previously [10].
This method generally yielded 25 mg of GcpE in 10 ml.
2.1. Determination of protein concentration and Fe content
Diﬀerent colorimetric assays resulted in diﬀerent estimates of the
amount of protein present in our preparations. To obtain an accurate
determination of the protein concentration an amino acid analysis was
performed at the Molecular Structure Facility, University of California
at Davis. The amino acid analysis gives both the type and amount of
amino acids present which can be used to calculate the exact protein
concentration. For the iron determination, protein samples were
passed over Chelex 100 to remove adventitiously bound iron. Iron
was determined using both atomic absorption spectrometry and a
rapid ferrozine-based colorimetric method [23]. Both methods gave
identical results.
2.2. Spectroscopic measurements
EPR spectra at X-band frequency (9 GHz) were obtained with a
Bruker EMX spectrometer. Cooling of the sample was performed with
an Oxford Instruments ESR 900 ﬂow cryostat with an ITC4 tempera-
ture controller. Spin quantization was carried out under non-saturat-
ing conditions using 10 mM copper perchlorate as the standard
(10 mM CuSO4; 2 mM NaClO4; 10 mM HCl). The software packagedeveloped by S.P.J. Albracht was used for computer simulations of
the EPR signals [24]. Variable temperature magnetic circular dichroism
(VTMCD) data and resonance Raman (RR) data were obtained as
previously described [25,26].3. Results and discussion
The GcpE protein was puriﬁed under the exclusion of mole-
cular oxygen. The puriﬁed protein contains 3.9 mol Fe per mol
of enzyme. The absorption spectrum of the as-isolated protein
showed the characteristic 420 nm band (Fig. 2), indicating the
presence of [4Fe–4S]2+ and/or [3Fe–4S]1+ clusters. Protein
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investigated in EPR or MCD spectroscopy. No signals were
detected in either the absence or presence of dithionite (con-
centrations up to 20 mM), which indicates that only diamag-
netic S = 0 [4Fe–4S]2+ clusters are present. The absorption
spectra in Fig. 2 show that incubation with dithionite did
not result in the reduction of the cluster, which should have
been detectable as a bleaching of the 420 nm band. Addition
of a stronger reductant like titanium(III) citrate did result in
bleaching of the sample, but no EPR signals were detected
due to [4Fe–4S]+, indicating that the cluster is probably broken
down under these conditions. The protein as-isolated was mea-
sured in resonance Raman (RR) spectroscopy. The position
and relative height of the bands in the 325–400 cm1 region
in Fig. 3 (panel a) are typical for regular [4Fe–4S]2+ clusters
with either 3 or 4 cysteine ligands [27,28]. The low-frequency
region, however, is diﬀerent. The typical 250 cm1 has a very
low intensity, while the 265 cm1 band is more intense. The
reason for this diﬀerence is not clear since these bands are asso-
ciated with internal Fe–S bonds [28]. Below we present evi-
dence for the possible binding of substrate to the reduced
[4Fe–4S]+ cluster. To test if MEcPP also binds to the [4Fe–
4S]2+ cluster, RR data were collected on the GcpE sample in
the presence of substrate. The spectrum (Fig. 3, panel b) is
identical to the RR spectrum in the absence of substrate.
Although this would indicate that MEcPP is probably not
binding it cannot be excluded that there is no eﬀect on the clus-
ter structure upon binding or whether a possible oxygen ligandFig. 3. Resonance Raman spectra of GcpE. (a) GcpE as isolated
(0.50 mM). (b) GcpE in the presence of 1.9 mM MEcPP. Each
spectrum is the sum of 40 scans, with 6 cm1 spectral bandwidth. The
peak marked with an asterisk is due to frozen water.from water that might be present is replaced with an oxygen
ligand from the substrate. Mo¨ssbauer experiments are planned
to investigate these possibilities.
The fact that dithionite cannot reduce the 4Fe cluster
(Fig. 2) is puzzling since it is the electron donor in the activity
assays [10]. To test the eﬀect of the addition of dithionite and
MEcPP on GcpE, the enzyme was investigated under steady-
state conditions in the presence of both compounds. In a typ-
ical experiment 0.10 mM GcpE in the presence of 4.0 mM
MEcPP was incubated at 55 C. The reaction was started
by adding dithionite with an end concentration of 4.7 mM.
With a speciﬁc activity of 0.6 lmol min1 mg1 the reaction
should last about 3 min. The development of EPR active spe-
cies was followed by transferring aliquots of the solution into
an EPR tube followed by ﬂash freezing the sample in cold
ethanol (200 K) at diﬀerent time intervals. During the ﬁrst
minute of the reaction a transient EPR signal is detected that
has its highest intensity in samples that were frozen within
10–12 s. The signal intensity decreases over time and is lost
after 1.5–2 min. Fig. 4 shows the spectrum of a sample frozen
after 10 s. The spectrum shows a rhombic EPR signal with
gxyz = 2.000, 2.019, and 2.087 and has a signal intensity of
0.6 spin relative to the protein concentration. The shape of
the EPR signal resembles that of a HiPIP-type [4Fe–4S]3+
cluster. The temperature behavior of the signal, however, is
not typical for such a cluster [29,30]. Below 20 K it is not
possible to measure the signal without saturation. From
20 K to 100 K the signal can be measured without saturation.
Above 100 K the signal starts to broaden and is broadened
beyond detection at 160 K. Another oddity is the fact that
the HiPIP signal is induced under reducing conditions and
not under strongly oxidizing conditions. Iron–sulfur clusters
with similar properties have been characterized in two other
proteins, ferredoxin:thioredoxin reductase (FTR) [31] andFig. 4. HiPIP-like EPR signal detected in GcpE during turn-over
experiments (a) and spectral simulation (b). The starting solution
contained 0.10 mM GcpE, 4.0 mM MEcPP and 4.7 mM dithionite in
2 ml of 100 mM Tris–HCl buﬀer, pH 8.0. Sample frozen after 10 s.
EPR conditions: microwave frequency, 9.388 GHz; microwave power
incident to the cavity, 2.01 mW; ﬁeld modulation frequency, 100 kHz;
modulation amplitude, 0.6 mT. Simulation parameters: gxyz = 1.9999,
2.0185, and 2.0874; Wxyz: 1.05, 0.95, and 1.50 mT.
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the reduction of a disulﬁde on a substrate in two one-electron
steps. A [4Fe–4S]2+ cluster is present in the active site in addi-
tion to an active-site disulﬁde. It was proposed that the role
of the 4Fe cluster is to stabilize the formal cysteinyl radical
that results from initial one-electron reduction of the active-
site disulﬁde, via reduction and coordination of one of the ac-
tive site cysteines to an Fe atom on the resultant oxidized
[4Fe–4S]3+ cluster [32]. With only three conserved cysteine
residues present in GcpE that are probably involved in the
coordination of the 4Fe cluster it can be assumed that there
is no active-site disulﬁde present in GcpE. In contrast to the
EPR signals found in FTR all the g values of the EPR signal
in GcpE are equal to 2 or higher [31]. This might be due to
the presence of one or two oxygen ligands from MEcPP in-
stead of the two cysteine sulfur atoms in FTR. Preliminary
ENDOR data show the presence of 31P-hyperﬁne coupling
on the transient GcpE EPR signal due to the close vicinity
of the MEcPP phosphate groups. Further investigation
should resolve the exact mode of binding of MEcPP, or an
intermediate, to the cluster.
From the spectral data and the Fe content of the GcpE
enzyme it can be concluded that in the anaerobically puriﬁed
samples the GcpE enzyme solely contains [4Fe–4S] clusters.
Based on the similarity of the EPR signals in GcpE and
FTR we propose that the transient signal detected in GcpE
is due to binding and stabilization of a radical-type intermedi-
ate by the 4Fe cluster. This is an important ﬁnding since sev-
eral mechanisms have been proposed in the literature
[10,13,16,33], but in only two papers was a direct role proposed
for the 4Fe cluster [11,34].
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